Literature DB >> 22425319

Platelet tissue factor pathway inhibitor modulates intravascular coagulation.

Susan A Maroney1, Alan E Mast.   

Abstract

Tissue factor pathway inhibitor (TFPI) is produced by megakaryocytes and is found internally within quiescent platelets but is not in α-granules. It is released in soluble form and expressed on the surface of platelets that are dual activated with thrombin plus collagen. Platelet TFPI is exclusively TFPIα, the most evolutionarily conserved TFPI isoform. It appears to be physiologically active as an inhibitor of tissue factor (TF) initiated FXa generation in vitro, and acts locally to dampen clot growth in a murine vascular injury model. These data suggest that platelet TFPI plays an important role in modulating TF activity within a growing clot thereby preventing formation of an occlusive clot.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22425319      PMCID: PMC3345333          DOI: 10.1016/j.thromres.2012.02.023

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  17 in total

1.  Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor.

Authors:  W F Novotny; M Palmier; T C Wun; G J Broze; J P Miletich
Journal:  Blood       Date:  1991-07-15       Impact factor: 22.113

2.  The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition.

Authors:  Matthew Ndonwi; Elodee A Tuley; George J Broze
Journal:  Blood       Date:  2010-05-17       Impact factor: 22.113

Review 3.  Structure and biology of tissue factor pathway inhibitor.

Authors:  M S Bajaj; J J Birktoft; S A Steer; S P Bajaj
Journal:  Thromb Haemost       Date:  2001-10       Impact factor: 5.249

4.  Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.

Authors:  M S Bajaj; M N Kuppuswamy; H Saito; S G Spitzer; S P Bajaj
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

5.  Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.

Authors:  W F Novotny; T J Girard; J P Miletich; G J Broze
Journal:  J Biol Chem       Date:  1989-11-05       Impact factor: 5.157

6.  TFPIbeta, a second product from the mouse tissue factor pathway inhibitor (TFPI) gene.

Authors:  J Y Chang; D M Monroe; J A Oliver; H R Roberts
Journal:  Thromb Haemost       Date:  1999-01       Impact factor: 5.249

7.  Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A.

Authors:  Ingrid Hrachovinová; Beatrice Cambien; Ali Hafezi-Moghadam; János Kappelmayer; Raymond T Camphausen; Angela Widom; Lijun Xia; Haig H Kazazian; Robert G Schaub; Rodger P McEver; Denisa D Wagner
Journal:  Nat Med       Date:  2003-07-13       Impact factor: 53.440

8.  Heparin induces release of extrinsic coagulation pathway inhibitor (EPI).

Authors:  P M Sandset; U Abildgaard; M L Larsen
Journal:  Thromb Res       Date:  1988-06-15       Impact factor: 3.944

9.  Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor.

Authors:  W F Novotny; T J Girard; J P Miletich; G J Broze
Journal:  Blood       Date:  1988-12       Impact factor: 22.113

10.  Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth.

Authors:  Susan A Maroney; Brian C Cooley; Josephine P Ferrel; Catherine E Bonesho; Alan E Mast
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-13       Impact factor: 8.311

View more
  3 in total

Review 1.  Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).

Authors:  Amir Hossein Norooznezhad; Kamran Mansouri
Journal:  Microvasc Res       Date:  2021-05-19       Impact factor: 3.514

2.  Quantitative high-throughput profiling of snake venom gland transcriptomes and proteomes (Ovophis okinavensis and Protobothrops flavoviridis).

Authors:  Steven D Aird; Yutaka Watanabe; Alejandro Villar-Briones; Michael C Roy; Kouki Terada; Alexander S Mikheyev
Journal:  BMC Genomics       Date:  2013-11-14       Impact factor: 3.969

3.  Thrombin generation abnormalities in commonly encountered platelet function disorders.

Authors:  Tanmya Sharma; Justin G Brunet; Subia Tasneem; Stephanie A Smith; James H Morrissey; Catherine P M Hayward
Journal:  Int J Lab Hematol       Date:  2021-06-29       Impact factor: 3.450

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.